150
Participants
Start Date
June 5, 2024
Primary Completion Date
October 31, 2026
Study Completion Date
October 31, 2026
RECRUITING
Murdoch Children's Research Institute, Parkville
RECRUITING
Haukeland University Hospital, Bergen
RECRUITING
Astrid Lindgren Children's Hospital, Solna
RECRUITING
Children's National Hospital, Washington D.C.
RECRUITING
Johns Hopkins School of Medicine, Baltimore
RECRUITING
Centre Hospitalier Universitaire (CHU) de Toulouse - Hôpital des Enfants, Toulouse
RECRUITING
Vanderbilt University Medical Center, Nashville
RECRUITING
Cincinnati Children's Hospital Medical Center, Cincinnati
RECRUITING
University of Wisconsin Madison - Waisman Center Bone Dysplasia Clinic, Madison
RECRUITING
University of Missouri, Columbia
RECRUITING
Hôpital Femme Mère Enfant HCL, Bron
RECRUITING
Hôpital Necker-Enfants Malades, Paris
RECRUITING
Childrens Hospital Colorado, Aurora
RECRUITING
UCSF Benioff Children's Hospital, Oakland
RECRUITING
KK Women's and Children's Hospital, Singapore
RECRUITING
London Health Sciences Centre - Children's Hospital of Western Ontario, London
RECRUITING
Children's Hospital of Eastern Ontario Research Institute, Ottawa
RECRUITING
Université de Montréal - Centre Hospitalier Universitaire Sainte-Justine, Montreal
RECRUITING
Paediatric Clinical Research Unit at Oslo University Hospital, Oslo
RECRUITING
Hospital Pediátrico de Coimbra, Coimbra
RECRUITING
Hospital Vithas San Jose, Vitoria-Gasteiz
RECRUITING
The Portland Hospital for Women and Children, London
RECRUITING
Manchester University, Manchester
RECRUITING
Sheffield Children's NHS Foundation Trust, Sheffield
RECRUITING
Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow
QED Therapeutics, Inc., a Bridgebio company
INDUSTRY